New research at Van Andel Research Institute may uncover origins of PD

News

Author: Almaz OhenePublished: 10 December 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

The Van Andel Research Institute (VARI) in Michigan, US, has expanded into new areas of research in molecular biology, genome-wide association studies (GWAS) and epigenetics in relation to Parkinson’s and Alzheimer’s diseases.

The centre claims that the new approach of ‘neuroepigenetics’ offers insights into uncovering the origins of Parkinson’s disease, and could be a key step in developing better ways to diagnose and treat the disease.

Peter Jones, VARI’s research director, said: “There is great potential for epigenetics to revolutionise our understanding of how neurodegenerative diseases occur and progress.”

Go Back

Share this story

Comments


Related articles


Resources & Tools

Perspectives on relationships, intimacy and Parkinson’s disease

Four women share insights in a Davis Phinney Foundation webinar

READ MORE
diabetes-drug-could-treat-Parkinsons

Advances

Can a diabetes drug be repurposed to treat Parkinson’s too?

Common diabetes drug may have potential to treat Parkinson’s

READ MORE
Focused Ultrasound Parkinson's Trial

Advances

A “world-first” trial for Parkinson’s disease

A new trial in Canada is investigating ultrasound technology

READ MORE